You have searched for "AztraZeneca"
Showing 1-10 of 10
Covid-19: Phase three of national immunisation programme in Klang Valley to start on Monday (June 21)
PUTRAJAYA (Bernama): The third phase of the National Covid-19 Immunisation Programme in the Klang Valley will begin on Monday (June 21) at the National Stadium vaccination centre (PPV) in Bukit Jalil here, says the programme's coordinating minister, Khairy Jamaluddin.
Here's a look at the news highlights from Asean countries in the Star-AseanPlus section for Monday (June 7)
The General Department of Prisons (GDP) is preparing to vaccinate prisoners with the AstraZeneca vaccine, marketed as Covishield, beginning on Monday in Preah Sihanouk province, followed by Kampong Speu and Kandal provinces.
PETALING JAYA: The timing interval between the first and second dose of the AstraZeneca vaccine for the opt-in programme is set at 12 weeks, says Khairy Jamaluddin.
PETALING JAYA: Some Malaysians are ensuring they are well-prepared ahead of the Covid-19 AztraZeneca vaccine registration on Sunday (May 2) and have set up contingency plans in the event of server glitches, lags, or website crashes due to a predicted rush of signups.
Thailand announced plans on Monday to go ahead with AstraZeneca's Covid-19 vaccine and Germany said it would continue to administer the shot despite other countries suspending its use over safety fears.
MANILA (Philippine Daily Inquirer/ANN): Amid criticisms over the delayed delivery of Covid-19 vaccines to the Philippines, the government “stands by” its vaccine cluster negotiating and procuring the jabs for the country, according to Cabinet Secretary Karlo Nograles.
ZURICH (Reuters) - Switzerland will start getting doses of COVID-19 vaccine from Pfizer and partner BioNTech within days after its drugs regulator authorised use of the jabs in what officials called the world's first approval under a standard procedure.
FRANKFURT/ZURICH (Reuters) - Dozens of drugmakers are conducting human trials for a record 89 therapies that pair antibodies with toxic agents to fight cancer, evidence of renewed confidence in an approach that has long fallen short of its promise, an analysis compiled for Reuters shows.